Mourisse L, Ostermann M, Thiessen S, Dumoulin A, et al. A multicenter randomized, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery. Intensive Care Med 2026 Sep 21. doi: 10.1007/s00134-026-08596.
PMID: 42766022